Login
Who's Online
We have 46 guests and no members online
Statistics
- Users 5462
- Articles 715
- Articles View Hits 16557634
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- CBER chief on remote work, CRISPR-Cas9, and rare disease gene therapy accelerated approval guidance - Regulatory Focus
Wed, 24 Apr 2024 23:26:0 GMT - U.S. Cell And Gene Therapy Manufacturing Market Size & Growth Report, 2033 - BioSpace
Wed, 24 Apr 2024 19:03:5 GMT - 2025 Cell & Gene Therapy Reimbursement Outlook - Genetic Engineering & Biotechnology News
Wed, 24 Apr 2024 18:00:4 GMT - Gene Therapy Revitalizes Brain Cells in Timothy Syndrome - Mirage News
Wed, 24 Apr 2024 17:24:0 GMT - GeneVentiv receives $2.5m grant for hemophilia gene therapy - Hemophilia News Today
Wed, 24 Apr 2024 17:00:3 GMT - Duchenne muscular dystrophy gene therapy trial shows promise - European Pharmaceutical Review
Wed, 24 Apr 2024 14:04:5 GMT - Ferring selects SK Pharmteco to manufacture gene therapy - BioProcess Insider
Wed, 24 Apr 2024 13:15:0 GMT - Sequencing Hope: New film details Alabama girl's historic gene therapy in Minnesota - KARE11.com
Wed, 24 Apr 2024 03:35:0 GMT - US FDA Gene Therapy Accelerated Approval Guidance Will Describe 'Buckets' Of Use Scenarios - Pink Sheet
Tue, 23 Apr 2024 23:26:5 GMT - LX2006 gene therapy now on FDA fast track for heart disease in FA - Friedreich's Ataxia News
Tue, 23 Apr 2024 19:32:2 GMT - First Clinical Trial Results of Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy Presented at International ... - Business Wire
Tue, 23 Apr 2024 18:49:0 GMT - FDA Issues CRL for Epidermolysis Bullosa Gene Therapy - Drug Topics
Tue, 23 Apr 2024 17:47:0 GMT - FDA rejects Abeona' Therapeutics' topical gene therapy pz-cel - FiercePharma
Tue, 23 Apr 2024 17:16:3 GMT - Mesenchymal stem cells as therapeutic vehicles for glioma | Cancer Gene Therapy - Nature.com
Tue, 23 Apr 2024 15:57:5 GMT - Groundbreaking Gene Therapy Brings Hope to Deaf Children - royalexaminer.com
Tue, 23 Apr 2024 15:37:1 GMT